Lymphoma News Today
@lymphomanewsWe exist to bring you science, research and clinical news about Lymphoma. We are a free digital publication dedicated to the patient community.
Similar User
@lymphoma
@JohnPLeonardMD
@LysaLymphoma
@DrJFriedberg
@Cure_FL
@frbertoni
@DrAnasYounes
@knowyournodes
@LYM_MM_CONNECT
@LymphomaCanada
@WCMLymphoma
@HenrychihangFu1
@GreenLymphoLab
@DrofBlood
@LymphomaAction
Help us shape the future of Lymphoma. BioNews Insights is aimed at increasing the awareness of the many aspects of the Lymphoma community. Your insight is essential to this goal. Click the link to participate in a survey now: bit.ly/3zEcfHN
New Post: $169K Raised by Local California Chapter in Annual Campaign of the Leukemia & Lymphoma Society buff.ly/2yfQ6So
New Post: Triumvira Cleared to Begin Clinical Testing of TAC01-CD19 in B-cell Lymphomas buff.ly/2ycVA0q
New Post: NantKwest Launches Phase 1 Trial to Assess Investigational Cell Therapy for B-cell Lymphomas buff.ly/2YdNxLl
New Post: Localized and Superficial Brain PCNS Lymphomas May Benefit from Surgery, Study Reviews Suggest buff.ly/2NXGSEX
New Post: FDA Grants Fast Track Status to Investigational Compound CLR 131 for DLBCL buff.ly/2lA2Ksl
New Post: Dosing Begins in Study of TP-0903, With or Without Imbruvica, for Advanced CLL and SLL buff.ly/2YTaO6u
New Post: TG Therapeutics to Seek Accelerated Approval of Umbralisib for Marginal Zone Lymphoma buff.ly/2YOJuGb
New Post: REGN1979 Eliminated Cancer in Most Non-Hodgkin’s Lymphoma Patients in Phase 1 Trial buff.ly/2LcwYgy
New Post: X4 Pharmaceuticals, LLS Collaborate to Develop Mavorixafor to Treat Waldenström’s Macroglobulinemia buff.ly/2YkIQQu
New Post: Copiktra Shows Promising Clinical Activity in PTCL Patients, Phase 1 Trials Show buff.ly/2IRHDuG
New Post: Pixuvri Gets Full Approval in Europe for Aggressive Non-Hodgkin’s B-cell Lymphomas, Servier Announced buff.ly/2Xp5iuz
New Post: Aliqopa Granted FDA’s Breakthrough Therapy Status for Previously Treated Marginal Zone Lymphoma buff.ly/2Fl6ULI
New Post: Forty Seven, Acerta Collaborate to Test Triple Combo Therapy on DLBCL Patients buff.ly/2XVF9kn
New Post: ME-401 Experimental Compound Reduces Tumor Burden in Follicular Lymphoma, Phase 1 Trial Shows buff.ly/2RiGBuh
United States Trends
- 1. Georgia 254 B posts
- 2. #MMA2024 150 B posts
- 3. Bob Bryar 14,2 B posts
- 4. Haynes King 12 B posts
- 5. 8 OTs 2.257 posts
- 6. #GoDawgs 12,4 B posts
- 7. Kirby 26,6 B posts
- 8. ATEEZ SHINES AT MMA 26,3 B posts
- 9. sohee 21,3 B posts
- 10. Nebraska 17,8 B posts
- 11. GA Tech 4.207 posts
- 12. Iowa 26,3 B posts
- 13. youngji 51,3 B posts
- 14. Brent Key 2.037 posts
- 15. Athens 10,9 B posts
- 16. 7th OT N/A
- 17. Reaves 4.433 posts
- 18. Carson Beck 4.709 posts
- 19. Trudeau 165 B posts
- 20. Dan Jackson 2.928 posts
Who to follow
-
Lymphoma Research Foundation
@lymphoma -
John P. Leonard, MD
@JohnPLeonardMD -
Lysa Lymphoma
@LysaLymphoma -
Jonathan Friedberg
@DrJFriedberg -
Follicular Lymphoma Foundation
@Cure_FL -
Francesco Bertoni
@frbertoni -
Anas Younes, M.D.
@DrAnasYounes -
Lymphoma Coalition
@knowyournodes -
LYMPHOMA & MYELOMA CONNECT
@LYM_MM_CONNECT -
Lymphoma Canada
@LymphomaCanada -
WCM Lymphoma
@WCMLymphoma -
MyelomaLymphoma
@HenrychihangFu1 -
Michael Green, PhD
@GreenLymphoLab -
Dr Blood
@DrofBlood -
LymphomaAction
@LymphomaAction
Something went wrong.
Something went wrong.